ORIGINAL ARTICLE

Pneumococcal, Influenza, Hepatitis B, and Tetanus Vaccination Rate and Vaccine Awareness in Patients with Type 2 Diabetes
Tip 2 Diyabetli Hastalarda Pnömokok, İnfluenza, Hepatit B, Tetanoz Aşılama Oranları ve Aşı Farkındalığı
Received Date : 05 Apr 2020
Accepted Date : 23 Jul 2020
Available Online : 31 Aug 2020
Doi: 10.25179/tjem.2020-75288 - Makale Dili: EN
Turk J Endocrinol Metab. 2020;24:327-334
Bu makale, CC BY-NC-SA altında lisanslanmış açık erişim bir makaledir.
ABSTRACT
Objective: This study aimed to determine the vaccination rates and the levels of awareness on pneumococcal, influenza, tetanus and hepatitis B vaccination among patients with Type 2 diabetes mellitus (DM). Material and Methods: The study was performed on patients with DM who presented to the outpatient Clinic of Internal Disease at Kartal Dr. Lütfi Kırdar City Hospital. Patients were asked to fill out a questionnaire regarding their vaccination status, attitude, and awareness about vaccines. Results: A total of 293 patients [121 (41.3%) males and 172 (58.7%) females] with a mean age of 65 years were included in the study. The mean duration of diabetes was 15 years. Overall, 47.8% of patients reported awareness about the need for vaccination while the rate of being unvaccinated was 52.2%. Reasons for the lack of vaccination were as follows: 67.3% of patients were unaware of the reason for not receiving vaccines; 17.5% patients did not want to be vaccinated; 13.3% patients reported that their physicians did not recommend vaccination; 1.5% reported unavailability of vaccines, and 0.4% reported negligence. Among vaccinated cases, 34.1% were vaccinated against flu; 20.8% against tetanus; 9.9% against pneumonia; 7.8% against hepatitis; and 5.1% received vaccination for other diseases. Conclusion: The levels of vaccine awareness and vaccination rates are low among diabetic patients. It is essential to raise vaccination awareness among this patient population. The health authorities and departments need to develop effective strategies to increase vaccination rates across the country.
ÖZET
Amaç: Bu çalışma, Tip 2 diabetes mellitus (DM) hastalarında aşılama oranlarını ve pnömokok, influenza, tetanoz ile hepatit B aşısı konusunda farkındalık düzeylerini belirlemeyi amaçlamaktadır. Gereç ve Yöntemler: Çalışma, Kartal Dr. Lütfi Kırdar Şehir Hastanesi İç Hastalıkları Kliniğine başvuran DM’li hastalar üzerinde yapıldı. Hastalardan aşı durumları, tutumları ve aşılarla ilgili farkındalıkları hakkında bir anket doldurmaları istendi. Bulgular: Çalışmaya, yaş ortalaması 65 yıl olan toplam 293 [121 (%41,3)’i erkek, 172 (%58,7)’si kadın] hasta dâhil edildi. Ortalama diyabet süresi 15 yıl idi. Genel olarak, hastaların %47,8’i aşılama ihtiyacı konusunda farkındalık bildirirken, aşı yaptırmama oranı da %52,2 idi. Hastaların %67,3’ü aşı olmama nedeninin farkında değildi. Yüzde 17,5 hasta aşı olmak istemediğini belirtirken; %13,3’ü, hekimlerinin kendilerine aşıyı önermediğini belirtti. Ayrıca hastaların %1,5’i aşıları bulamadığını, %0,4’ü de aşı olmayı ihmal ettiğini bildirdi. Aşılanan olguların %34,1’i grip aşısı; %20,8’i tetanoz; %9,9’u pnömoni; %7,8’i hepatit ve %5,1’i de diğer hastalıklara karşı aşılanmıştır. Sonuç: Diyabetik hastalarda aşı farkındalığı ve aşılama oranları düşük olarak bulundu. Bu hasta popülasyonunda aşılama bilincinin artırılması esastır. Sağlık yetkilileri ve kuruluşlarının, ülke genelinde aşılama oranlarını artırmak için etkili stratejiler geliştirmesi gerektiği düşünülmektedir.
KAYNAKLAR
  1. Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383:999-1008. [Crossref]  [PubMed]  [PMC] 
  2. Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16 Suppl 1:S27-S36. [Crossref]  [PubMed]  [PMC] 
  3. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14:29-34. [Crossref]  [PubMed] 
  4. Wang IK, Lin CL, Chang YC, Lin PC, Liang CC, Liu YL, Chang CT, Yen TH, Huang CC, Sung FC. Effectiveness of influenza vaccination in elderly diabetic patients: a retrospective cohort study. Vaccine. 2013;31:718-724. [Crossref]  [PubMed] 
  5. Giannattasio A, Squeglia V, Lo Vecchio A, Russo MT, Barbarino A, Carlomagno R, Guarino A. Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions. Ital J Pediatr. 2010;36:28. [Crossref]  [PubMed]  [PMC] 
  6. Bouter KP, Diepersloot RJ, van Romunde LK, Uitslager R, Masurel N, Hoekstra JB, Erkelens DW. Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands. Diabetes Res Clin Pract. 1991;12:61-68. [Crossref]  [PubMed] 
  7. Türkiye Diyabet Vakfı, Türk Diyabet Cemiyeti, Türkiye Endokrinoloji ve Metabolizma Derneği, Diyabet Hemşireliği Derneği. Diyabetik Birey Aşılama Rehberi. [Link] 
  8. Williams WW, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, Rodriguez-Lainz A, Fiebelkorn AP. Surveillance of vaccination coverage among adult populations - United States, 2015. MMWR Surveill Summ 2017;66:1-28. [Crossref]  [PMC] 
  9. Krasselt M, Ivanov JP, Baerwald C, Seifert O. Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic. Rheumatol Int. 2017;37:229-237. [Crossref]  [PubMed] 
  10. EuroStat. 44% of elderly people vaccinated against influenza. 2019. (Date of Access: 31.03.2020) [Link] 
  11. Quach S, Hamid JS, Pereira JA, Heidebrecht CL, Deeks SL, Crowcroft NS, Quan SD, Brien S, Kwong JC; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Vaccine Coverage Theme Group. Influenza vaccination coverage across ethnic groups in Canada. CMAJ. 2012;184:1673-1681. [Crossref]  [PubMed]  [PMC] 
  12. Dower J, Donald M, Begum N, Vlack S, Ozolins I. Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia. Vaccine. 2011;29:3031-3037. [Crossref]  [PubMed] 
  13. Arslan İE, Altınova A, Baloş Törüner F, Yalçın MM, Özkan Ç, Müjde NÇ, Arslan AM. Diyabetik hastaların hepatit-B, influenza ve pnömokok aşı farkındalıkları. Gazi Med J. 2016;27:115-117. [Link] 
  14. Satman I, Akalin S, Cakir B, Altinel S; diaVAX Study Group. The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study "diaVAX". Hum Vaccin Immunother. 2013;9:2618-2626. [Crossref]  [PubMed]  [PMC] 
  15. Sahin S, Tasar PT, Guclu YA, Sengul HS, Bozkurt N, Garip A, Duman S, Akcicek F. Vaccinations rates in the elderly with diabetes mellitus. Adv Aging Res. 2014;3:293-296. [Crossref] 
  16. Ünal S, Durusu Tanrıöver M, Taş E, Güner İ, Çetin ÖY, Sayar İ. Aile hekimlerine eğitim verilmesi ve aşilama hedeflerinin belirlenmesinin pnömokok aşılanma oranları üzerine etkileri. Flora. 2015;20:10-15.
  17. Ciblak MA; Grip Platformu. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31:518-523. [Crossref]  [PubMed] 
  18. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362:1733-1745. [Crossref]  [PubMed] 
  19. Collins JP, Campbell AP, Openo K, Farley MM, Cummings CN, Hill M, Schaffner W, Lindegren ML, Thomas A, Billing L, Bennett N, Spina N, Bargsten M, Lynfield R, Eckel S, Ryan P, Yousey-Hindes K, Herlihy R, Kirley PD, Garg S, Anderson EJ. Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015. Clin Infect Dis. 2020;70:2121-2130. [Crossref]  [PubMed]  [PMC] 
  20. LaVela SL, Smith B, Weaver FM, Legro MW, Goldstein B, Nichol K. Attitudes and practices regarding influenza vaccination among healthcare workers providing services to individuals with spinal cord injuries and disorders. Infect Control Hosp Epidemiol. 2004;25:933-940. [Crossref]  [PubMed] 
  21. Jimenez-Trujillo I, López-de Andrés A, Hernández-Barrera V, Carrasco-Garrido P, Santos-Sancho JM, Jiménez-García R. Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain. Hum Vaccin Immunother. 2013;9:1326-1332. [Crossref]  [PubMed]  [PMC]